FDA Law Blog

NOVEMBER 10, 2024

Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field. In October, FDA announced seven new clinical trial grants awarded in fiscal year (FY) 2024 – including one for a Phase 3 trial – totaling $17.2

Production 69

Production Clinical Development Development Regulation 69

pharmaphorum

JANUARY 5, 2021

An IQVIA survey to Neurology, Cardiology, Rheumatology, Dermatology and Ophthalmologists in June 2020 across the lead five European countries showed an average of 30% of patients either “no shows” or still waiting for treatment that was delayed.

Sales 105

Sales Marketing Production Vaccination 105

The Pharma Data

SEPTEMBER 15, 2020

The company announced the initiation of its Phase 1b clinical trial to evaluate the safety of a novel investigational therapeutic for COVID-19, PF-07304814. Based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October. Protease Inhibitor Program. and -50.4%

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. The canakinumab development program continues, with two Ph3 non-small cell lung cancer clinical trials ongoing in first-line and adjuvant setting. Adakveo sales reached USD 37 million.

Sales 40

Sales Medicine Production Manufacturing 40

XTalks

AUGUST 2, 2023

Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. At present, the company has approximately 45 new drugs in Phase II or Phase III clinical trials, or awaiting approval from regulatory authorities in the US, Europe or Japan. billion ($3.65

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharma Marketing Network

MARCH 19, 2025

Strategies to Engage Healthcare Professionals (HCPs) Provide High-Value Educational Content HCPs seek content that enhances their clinical knowledge and informs their prescribing decisions. Optimize for Mobile and Microlearning Many HCPs consume medical content on the go.

Marketing 52

Marketing Branding Compliance Cardiology 52